| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.26e-12 | 43 | 18 | 6 | GO:0030280 | |
| GeneOntologyMolecularFunction | structural molecule activity | 9.08e-05 | 891 | 18 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 6.01e-03 | 130 | 18 | 2 | GO:0005200 | |
| GeneOntologyMolecularFunction | lipid binding | 1.04e-02 | 988 | 18 | 4 | GO:0008289 | |
| GeneOntologyBiologicalProcess | keratinization | SPRR4 LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 9.04e-39 | 87 | 20 | 17 | GO:0031424 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | SPRR4 LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 1.21e-32 | 189 | 20 | 17 | GO:0030216 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | SPRR4 LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 1.56e-29 | 284 | 20 | 17 | GO:0009913 |
| GeneOntologyBiologicalProcess | skin development | SPRR4 LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 1.78e-27 | 373 | 20 | 17 | GO:0043588 |
| GeneOntologyBiologicalProcess | epidermis development | SPRR4 LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 6.94e-26 | 461 | 20 | 17 | GO:0008544 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | SPRR4 LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 3.68e-21 | 870 | 20 | 17 | GO:0030855 |
| GeneOntologyBiologicalProcess | epithelium development | SPRR4 LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 2.65e-17 | 1469 | 20 | 17 | GO:0060429 |
| GeneOntologyBiologicalProcess | peptide cross-linking | 2.25e-06 | 27 | 20 | 3 | GO:0018149 | |
| GeneOntologyBiologicalProcess | response to estradiol | 6.35e-06 | 128 | 20 | 4 | GO:0032355 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 3.92e-04 | 150 | 20 | 3 | GO:0050830 | |
| GeneOntologyBiologicalProcess | cell killing | 3.09e-03 | 307 | 20 | 3 | GO:0001906 | |
| GeneOntologyCellularComponent | cornified envelope | 1.52e-13 | 69 | 19 | 7 | GO:0001533 | |
| MousePheno | decreased urine creatinine level | 6.95e-05 | 26 | 7 | 2 | MP:0011471 | |
| MousePheno | abnormal urine creatinine level | 1.06e-04 | 32 | 7 | 2 | MP:0011469 | |
| MousePheno | abnormal urine amino acid level | 3.63e-04 | 59 | 7 | 2 | MP:0011468 | |
| Domain | SPRR/LCE | SPRR4 PRR9 SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 2.14e-48 | 28 | 20 | 17 | IPR026075 |
| Domain | LCE | 5.35e-24 | 17 | 20 | 9 | IPR028205 | |
| Domain | LCE | 5.35e-24 | 17 | 20 | 9 | PF14672 | |
| Domain | SPRR2 | 4.91e-15 | 6 | 20 | 5 | PF14820 | |
| Domain | SPRR2 | 4.91e-15 | 6 | 20 | 5 | IPR029142 | |
| Domain | Cornifin | 4.20e-09 | 4 | 20 | 3 | IPR003302 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 1.39e-31 | 129 | 18 | 16 | M27649 |
| Pathway | REACTOME_KERATINIZATION | LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 8.47e-28 | 217 | 18 | 16 | M27640 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 1.49e-14 | 1432 | 18 | 16 | M509 |
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | LCE3D SPRR1A SPRR1B LCE2D LCE2C LCE3B LCE2A LCE4A LCE3E LCE3C LCE2B | 2.11e-31 | 23 | 21 | 11 | 11698679 |
| Pubmed | 7.11e-25 | 22 | 21 | 9 | 15854049 | ||
| Pubmed | 1.90e-24 | 12 | 21 | 8 | 18643845 | ||
| Pubmed | 4.92e-23 | 16 | 21 | 8 | 17410201 | ||
| Pubmed | Mouse Sprr locus: a tandem array of coordinately regulated genes. | 7.62e-23 | 8 | 21 | 7 | 12584609 | |
| Pubmed | 7.62e-23 | 8 | 21 | 7 | 15574822 | ||
| Pubmed | 1.14e-21 | 10 | 21 | 7 | 8325635 | ||
| Pubmed | 7.53e-21 | 12 | 21 | 7 | 9888996 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | SPRR4 LCE3D SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E LCE3C | 4.99e-19 | 1031 | 21 | 15 | 16710414 |
| Pubmed | 1.85e-18 | 9 | 21 | 6 | 11279051 | ||
| Pubmed | 1.27e-17 | 62 | 21 | 8 | 26644517 | ||
| Pubmed | Estrogen regulates the expression of the small proline-rich 2 gene family in the mouse uterus. | 2.69e-15 | 8 | 21 | 5 | 15232223 | |
| Pubmed | 3.88e-15 | 25 | 21 | 6 | 31410202 | ||
| Pubmed | ZFP750 affects the cutaneous barrier through regulating lipid metabolism. | 1.61e-14 | 31 | 21 | 6 | 37115925 | |
| Pubmed | 9.82e-14 | 4 | 21 | 4 | 11350120 | ||
| Pubmed | 4.91e-13 | 5 | 21 | 4 | 11159194 | ||
| Pubmed | 4.91e-13 | 5 | 21 | 4 | 3133554 | ||
| Pubmed | 3.43e-12 | 7 | 21 | 4 | 31884525 | ||
| Pubmed | 6.86e-12 | 8 | 21 | 4 | 11038185 | ||
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 4.80e-11 | 630 | 21 | 9 | 36949045 | |
| Pubmed | The mineralocorticoid receptor plays a transient role in mouse skin development. | 7.00e-11 | 13 | 21 | 4 | 26268211 | |
| Pubmed | Fate and plasticity of the epidermis in response to congenital activation of BRAF. | 7.00e-11 | 13 | 21 | 4 | 25202828 | |
| Pubmed | Amniotic fluid activates the nrf2/keap1 pathway to repair an epidermal barrier defect in utero. | 9.79e-11 | 14 | 21 | 4 | 23237955 | |
| Pubmed | Novel markers of early ovarian pre-granulosa cells are expressed in an Sry-like pattern. | 9.79e-11 | 14 | 21 | 4 | 19301398 | |
| Pubmed | 1.33e-10 | 15 | 21 | 4 | 20880987 | ||
| Pubmed | 1.78e-10 | 16 | 21 | 4 | 21930775 | ||
| Pubmed | 4.73e-10 | 20 | 21 | 4 | 21466799 | ||
| Pubmed | 7.13e-10 | 22 | 21 | 4 | 16949565 | ||
| Pubmed | 7.13e-10 | 22 | 21 | 4 | 24899573 | ||
| Pubmed | Expression and regulation of cornified envelope proteins in human corneal epithelium. | 7.59e-10 | 4 | 21 | 3 | 16639001 | |
| Pubmed | Insulin/IGF-1 controls epidermal morphogenesis via regulation of FoxO-mediated p63 inhibition. | 1.23e-09 | 25 | 21 | 4 | 23906066 | |
| Pubmed | 1.23e-09 | 25 | 21 | 4 | 23132931 | ||
| Pubmed | 1.46e-09 | 26 | 21 | 4 | 15454262 | ||
| Pubmed | 3.06e-09 | 31 | 21 | 4 | 20930145 | ||
| Pubmed | Ovarian development in mice requires the GATA4-FOG2 transcription complex. | 5.71e-09 | 36 | 21 | 4 | 18927154 | |
| Pubmed | CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins. | 6.63e-09 | 7 | 21 | 3 | 36804407 | |
| Pubmed | 8.85e-09 | 40 | 21 | 4 | 19864314 | ||
| Pubmed | 4.68e-08 | 60 | 21 | 4 | 31220272 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21435436 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20213803 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 22384135 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21400479 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 24566688 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21628307 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21509048 | ||
| Pubmed | MiR-463-3p inhibits tibial nerve regeneration via post-transcriptional suppression of SPRR1A. | 3.47e-07 | 2 | 21 | 2 | 31468997 | |
| Pubmed | Deletion of LCE3C and LCE3B genes is associated with psoriasis in a northern Chinese population. | 3.47e-07 | 2 | 21 | 2 | 21711330 | |
| Pubmed | Deletion of Late Cornified Envelope 3B and 3C genes is not associated with atopic dermatitis. | 3.47e-07 | 2 | 21 | 2 | 20376060 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 10771479 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21995181 | ||
| Pubmed | Structure and organization of the genes encoding mouse small proline-rich proteins, mSPRR1A and 1B. | 3.47e-07 | 2 | 21 | 2 | 9931436 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 22048733 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20331852 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 34942199 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19107756 | ||
| Pubmed | Sequence and expression patterns of mouse SPR1: Correlation of expression with epithelial function. | 3.47e-07 | 2 | 21 | 2 | 8601731 | |
| Pubmed | LCE3C_LCE3B-del genotype and psoriasis: a summative meta-analysis. | 3.47e-07 | 2 | 21 | 2 | 20624365 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 23631431 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19097987 | ||
| Pubmed | SPRR1B overexpression enhances entry of cells into the G0 phase of the cell cycle. | 3.47e-07 | 2 | 21 | 2 | 12832281 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 24485035 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 28859701 | ||
| Pubmed | Association analysis of LCE3C-LCE3B deletion in Tunisian psoriatic population. | 3.47e-07 | 2 | 21 | 2 | 22926764 | |
| Pubmed | ZNF750 Regulates Skin Barrier Function by Driving Cornified Envelope and Lipid Processing Pathways. | 4.33e-07 | 25 | 21 | 3 | 37660780 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 9722562 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 37468478 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 11850458 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 7829876 | ||
| Pubmed | Psoriasis-Associated Late Cornified Envelope (LCE) Proteins Have Antibacterial Activity. | 1.04e-06 | 3 | 21 | 2 | 28634035 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 20016497 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 21107349 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 19169253 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 34403363 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 27048876 | ||
| Pubmed | Protein-protein interaction panel using mouse full-length cDNAs. | 2.49e-06 | 161 | 21 | 4 | 11591653 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 22512642 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 9115270 | ||
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 10441742 | ||
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 27304082 | ||
| Pubmed | 5.54e-06 | 197 | 21 | 4 | 32434143 | ||
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 10908733 | ||
| Pubmed | 9.70e-06 | 8 | 21 | 2 | 7543090 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.22e-05 | 910 | 21 | 6 | 36736316 | |
| Pubmed | Loss-of-function mutations in FREM2 disrupt eye morphogenesis. | 1.90e-05 | 11 | 21 | 2 | 30802441 | |
| Pubmed | 1.90e-05 | 11 | 21 | 2 | 32467224 | ||
| Pubmed | TFEB regulates murine liver cell fate during development and regeneration. | 2.70e-05 | 13 | 21 | 2 | 32424153 | |
| Pubmed | Lymphotoxin-beta regulates periderm differentiation during embryonic skin development. | 3.15e-05 | 14 | 21 | 2 | 17673451 | |
| Pubmed | Creation of genome-wide protein expression libraries using random activation of gene expression. | 6.33e-05 | 367 | 21 | 4 | 11329013 | |
| Pubmed | Bcl11b/Ctip2 is required for development of lingual papillae in mice. | 7.24e-05 | 21 | 21 | 2 | 27287879 | |
| Pubmed | 7.24e-05 | 21 | 21 | 2 | 24198274 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 7.24e-05 | 21 | 21 | 2 | 19601998 | |
| Pubmed | 7.96e-05 | 22 | 21 | 2 | 31597917 | ||
| Pubmed | 8.72e-05 | 23 | 21 | 2 | 19494835 | ||
| Pubmed | Neonatal Wnt-dependent Lgr5 positive stem cells are essential for uterine gland development. | 9.51e-05 | 24 | 21 | 2 | 31772170 | |
| Pubmed | Transcription Factor MafB Coordinates Epidermal Keratinocyte Differentiation. | 9.51e-05 | 24 | 21 | 2 | 27208706 | |
| Pubmed | Barx2 functions through distinct corepressor classes to regulate hair follicle remodeling. | 9.51e-05 | 24 | 21 | 2 | 15728386 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 3.03e-04 | 552 | 21 | 4 | 10737800 | |
| Pubmed | Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice. | 3.38e-04 | 45 | 21 | 2 | 28973166 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 5.23e-04 | 1155 | 21 | 5 | 20360068 | |
| Interaction | KRTAP5-2 interactions | 1.21e-18 | 62 | 19 | 9 | int:KRTAP5-2 | |
| Interaction | KRTAP5-4 interactions | 1.41e-18 | 63 | 19 | 9 | int:KRTAP5-4 | |
| Interaction | KRTAP4-5 interactions | 8.47e-18 | 76 | 19 | 9 | int:KRTAP4-5 | |
| Interaction | KRTAP4-4 interactions | 1.55e-17 | 81 | 19 | 9 | int:KRTAP4-4 | |
| Interaction | KRTAP10-6 interactions | 3.38e-17 | 88 | 19 | 9 | int:KRTAP10-6 | |
| Interaction | RGS17 interactions | 4.15e-17 | 48 | 19 | 8 | int:RGS17 | |
| Interaction | KRTAP4-11 interactions | 5.13e-17 | 92 | 19 | 9 | int:KRTAP4-11 | |
| Interaction | KRTAP5-6 interactions | 6.27e-17 | 94 | 19 | 9 | int:KRTAP5-6 | |
| Interaction | KRTAP9-8 interactions | 1.12e-16 | 100 | 19 | 9 | int:KRTAP9-8 | |
| Interaction | KRTAP10-11 interactions | 4.83e-16 | 64 | 19 | 8 | int:KRTAP10-11 | |
| Interaction | KRTAP5-3 interactions | 6.26e-16 | 66 | 19 | 8 | int:KRTAP5-3 | |
| Interaction | LCE2A interactions | 9.10e-16 | 69 | 19 | 8 | int:LCE2A | |
| Interaction | KRTAP5-7 interactions | 1.16e-15 | 71 | 19 | 8 | int:KRTAP5-7 | |
| Interaction | KRTAP4-2 interactions | 1.47e-15 | 132 | 19 | 9 | int:KRTAP4-2 | |
| Interaction | KRTAP9-3 interactions | 2.53e-15 | 140 | 19 | 9 | int:KRTAP9-3 | |
| Interaction | LCE2B interactions | 3.48e-15 | 81 | 19 | 8 | int:LCE2B | |
| Interaction | KRTAP9-2 interactions | 4.48e-15 | 149 | 19 | 9 | int:KRTAP9-2 | |
| Interaction | KRTAP10-1 interactions | 5.72e-15 | 153 | 19 | 9 | int:KRTAP10-1 | |
| Interaction | KRTAP10-5 interactions | 8.62e-15 | 160 | 19 | 9 | int:KRTAP10-5 | |
| Interaction | KRTAP4-12 interactions | 9.13e-15 | 161 | 19 | 9 | int:KRTAP4-12 | |
| Interaction | KRTAP1-5 interactions | 1.36e-14 | 48 | 19 | 7 | int:KRTAP1-5 | |
| Interaction | KRTAP1-3 interactions | 3.09e-14 | 184 | 19 | 9 | int:KRTAP1-3 | |
| Interaction | KRTAP5-9 interactions | 7.57e-14 | 203 | 19 | 9 | int:KRTAP5-9 | |
| Interaction | RGS20 interactions | 7.78e-14 | 118 | 19 | 8 | int:RGS20 | |
| Interaction | KRTAP5-11 interactions | 1.42e-13 | 66 | 19 | 7 | int:KRTAP5-11 | |
| Interaction | KRTAP1-1 interactions | 1.51e-13 | 219 | 19 | 9 | int:KRTAP1-1 | |
| Interaction | LCE2D interactions | 3.27e-13 | 74 | 19 | 7 | int:LCE2D | |
| Interaction | KRTAP10-9 interactions | 3.59e-13 | 241 | 19 | 9 | int:KRTAP10-9 | |
| Interaction | KRTAP12-3 interactions | 4.42e-13 | 146 | 19 | 8 | int:KRTAP12-3 | |
| Interaction | TRIM42 interactions | 5.21e-13 | 149 | 19 | 8 | int:TRIM42 | |
| Interaction | LCE1A interactions | 8.19e-13 | 84 | 19 | 7 | int:LCE1A | |
| Interaction | LCE1B interactions | 8.92e-13 | 85 | 19 | 7 | int:LCE1B | |
| Interaction | LCE2C interactions | 1.15e-12 | 88 | 19 | 7 | int:LCE2C | |
| Interaction | LCE5A interactions | 1.35e-12 | 90 | 19 | 7 | int:LCE5A | |
| Interaction | LCE1F interactions | 1.58e-12 | 92 | 19 | 7 | int:LCE1F | |
| Interaction | KRTAP2-3 interactions | 1.99e-12 | 95 | 19 | 7 | int:KRTAP2-3 | |
| Interaction | KRTAP10-7 interactions | 2.09e-12 | 293 | 19 | 9 | int:KRTAP10-7 | |
| Interaction | KRTAP2-4 interactions | 3.08e-12 | 101 | 19 | 7 | int:KRTAP2-4 | |
| Interaction | KRTAP17-1 interactions | 3.50e-12 | 48 | 19 | 6 | int:KRTAP17-1 | |
| Interaction | SPRY1 interactions | 6.06e-12 | 111 | 19 | 7 | int:SPRY1 | |
| Interaction | ADAMTSL4 interactions | 1.08e-11 | 217 | 19 | 8 | int:ADAMTSL4 | |
| Interaction | NBPF19 interactions | 1.92e-11 | 233 | 19 | 8 | int:NBPF19 | |
| Interaction | KRTAP10-8 interactions | 3.46e-11 | 401 | 19 | 9 | int:KRTAP10-8 | |
| Interaction | LCE1D interactions | 3.69e-11 | 70 | 19 | 6 | int:LCE1D | |
| Interaction | LCE3A interactions | 6.14e-11 | 76 | 19 | 6 | int:LCE3A | |
| Interaction | LCE1C interactions | 6.65e-11 | 77 | 19 | 6 | int:LCE1C | |
| Interaction | KRTAP4-1 interactions | 7.03e-11 | 31 | 19 | 5 | int:KRTAP4-1 | |
| Interaction | LCE4A interactions | 8.42e-11 | 80 | 19 | 6 | int:LCE4A | |
| Interaction | CYSRT1 interactions | 2.98e-10 | 511 | 19 | 9 | int:CYSRT1 | |
| Interaction | HOXA1 interactions | 5.59e-10 | 356 | 19 | 8 | int:HOXA1 | |
| Interaction | NOTCH2NLA interactions | 9.56e-10 | 381 | 19 | 8 | int:NOTCH2NLA | |
| Interaction | ALPP interactions | 1.16e-09 | 123 | 19 | 6 | int:ALPP | |
| Interaction | TSPAN4 interactions | 1.17e-09 | 53 | 19 | 5 | int:TSPAN4 | |
| Interaction | VWC2 interactions | 2.63e-09 | 62 | 19 | 5 | int:VWC2 | |
| Interaction | LCE1E interactions | 4.22e-09 | 68 | 19 | 5 | int:LCE1E | |
| Interaction | VASN interactions | 5.68e-09 | 160 | 19 | 6 | int:VASN | |
| Interaction | KRTAP6-3 interactions | 5.89e-09 | 161 | 19 | 6 | int:KRTAP6-3 | |
| Interaction | LCE3D interactions | 6.06e-09 | 73 | 19 | 5 | int:LCE3D | |
| Interaction | KRTAP3-2 interactions | 9.07e-09 | 79 | 19 | 5 | int:KRTAP3-2 | |
| Interaction | KRTAP3-3 interactions | 1.10e-08 | 82 | 19 | 5 | int:KRTAP3-3 | |
| Interaction | CYP21A2 interactions | 2.27e-08 | 33 | 19 | 4 | int:CYP21A2 | |
| Interaction | PTK6 interactions | 3.65e-08 | 104 | 19 | 5 | int:PTK6 | |
| Interaction | LCE3B interactions | 8.98e-08 | 46 | 19 | 4 | int:LCE3B | |
| Interaction | EFEMP2 interactions | 1.40e-07 | 136 | 19 | 5 | int:EFEMP2 | |
| Interaction | KRTAP12-4 interactions | 1.60e-07 | 53 | 19 | 4 | int:KRTAP12-4 | |
| Interaction | OTX1 interactions | 2.69e-07 | 155 | 19 | 5 | int:OTX1 | |
| Interaction | CRCT1 interactions | 3.92e-07 | 66 | 19 | 4 | int:CRCT1 | |
| Interaction | LCE3C interactions | 4.16e-07 | 67 | 19 | 4 | int:LCE3C | |
| Interaction | CHIC2 interactions | 5.89e-07 | 73 | 19 | 4 | int:CHIC2 | |
| Interaction | SMCP interactions | 8.11e-07 | 79 | 19 | 4 | int:SMCP | |
| Interaction | KRTAP10-10 interactions | 2.05e-06 | 27 | 19 | 3 | int:KRTAP10-10 | |
| Interaction | KRTAP9-4 interactions | 3.81e-06 | 33 | 19 | 3 | int:KRTAP9-4 | |
| Interaction | SPRY3 interactions | 4.56e-06 | 35 | 19 | 3 | int:SPRY3 | |
| Interaction | GRN interactions | 5.04e-06 | 281 | 19 | 5 | int:GRN | |
| Interaction | SPRY2 interactions | 1.10e-05 | 152 | 19 | 4 | int:SPRY2 | |
| Interaction | CCR1 interactions | 1.70e-05 | 361 | 19 | 5 | int:CCR1 | |
| Interaction | KRTAP12-1 interactions | 2.72e-05 | 63 | 19 | 3 | int:KRTAP12-1 | |
| Interaction | NUFIP2 interactions | 3.39e-05 | 417 | 19 | 5 | int:NUFIP2 | |
| Interaction | MDFI interactions | 3.92e-05 | 430 | 19 | 5 | int:MDFI | |
| Interaction | KRTAP3-1 interactions | 6.68e-05 | 85 | 19 | 3 | int:KRTAP3-1 | |
| Interaction | GUCD1 interactions | 7.41e-05 | 88 | 19 | 3 | int:GUCD1 | |
| Interaction | KPRP interactions | 1.27e-04 | 284 | 19 | 4 | int:KPRP | |
| Interaction | KRTAP11-1 interactions | 1.36e-04 | 108 | 19 | 3 | int:KRTAP11-1 | |
| Interaction | PCSK5 interactions | 1.52e-04 | 112 | 19 | 3 | int:PCSK5 | |
| Interaction | PLA2G10 interactions | 1.56e-04 | 113 | 19 | 3 | int:PLA2G10 | |
| Interaction | TGFB1 interactions | 1.93e-04 | 317 | 19 | 4 | int:TGFB1 | |
| Interaction | KRTAP12-2 interactions | 2.25e-04 | 128 | 19 | 3 | int:KRTAP12-2 | |
| Interaction | ITGA9 interactions | 2.70e-04 | 26 | 19 | 2 | int:ITGA9 | |
| Interaction | CREB5 interactions | 4.66e-04 | 164 | 19 | 3 | int:CREB5 | |
| Interaction | PLSCR1 interactions | 5.35e-04 | 172 | 19 | 3 | int:PLSCR1 | |
| Interaction | MACO1 interactions | 5.63e-04 | 175 | 19 | 3 | int:MACO1 | |
| Interaction | SUMO1P1 interactions | 6.76e-04 | 41 | 19 | 2 | int:SUMO1P1 | |
| Interaction | SLC39A7 interactions | 6.83e-04 | 187 | 19 | 3 | int:SLC39A7 | |
| Interaction | KRT31 interactions | 7.47e-04 | 453 | 19 | 4 | int:KRT31 | |
| Interaction | PLSCR3 interactions | 9.26e-04 | 48 | 19 | 2 | int:PLSCR3 | |
| Interaction | LCE3E interactions | 1.44e-03 | 60 | 19 | 2 | int:LCE3E | |
| Interaction | NR4A3 interactions | 1.90e-03 | 69 | 19 | 2 | int:NR4A3 | |
| Interaction | KRTAP10-3 interactions | 2.50e-03 | 294 | 19 | 3 | int:KRTAP10-3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | SPRR4 PRR9 LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C SPRR2F LCE3B LCE2A LCE4A LCE3E SPRR5 LCE3C LCE2B | 1.19e-37 | 404 | 21 | 19 | chr1q21 |
| Cytoband | 1q21-q22 | 3.33e-19 | 23 | 21 | 7 | 1q21-q22 | |
| Cytoband | 1q21.3 | 9.49e-19 | 117 | 21 | 9 | 1q21.3 | |
| Cytoband | 1q21 | 7.96e-04 | 91 | 21 | 2 | 1q21 | |
| GeneFamily | Late cornified envelope proteins | 4.15e-24 | 18 | 18 | 9 | 627 | |
| GeneFamily | Small proline rich proteins | 2.55e-23 | 11 | 18 | 8 | 1353 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_UP | 9.48e-10 | 20 | 19 | 4 | MM491 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 1.73e-09 | 23 | 19 | 4 | MM492 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | 1.28e-08 | 689 | 19 | 8 | MM1041 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 1.36e-08 | 694 | 19 | 8 | MM1039 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 4.09e-08 | 49 | 19 | 4 | MM452 | |
| Coexpression | DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS | 2.05e-06 | 129 | 19 | 4 | M40122 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS | 2.84e-06 | 140 | 19 | 4 | M40004 | |
| Coexpression | AMIT_SERUM_RESPONSE_480_MCF10A | 2.90e-06 | 39 | 19 | 3 | M8202 | |
| Coexpression | BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP | 3.18e-06 | 144 | 19 | 4 | M34020 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_UP | 4.04e-06 | 153 | 19 | 4 | MM495 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_UP | 6.88e-06 | 175 | 19 | 4 | MM499 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP | 6.88e-06 | 175 | 19 | 4 | MM501 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 9.91e-06 | 741 | 19 | 6 | MM1037 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_UP | 9.92e-06 | 192 | 19 | 4 | MM497 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 1.26e-05 | 204 | 19 | 4 | MM966 | |
| Coexpression | BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE | 1.64e-05 | 69 | 19 | 3 | M2533 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C1 | 2.03e-05 | 74 | 19 | 3 | M7933 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 2.34e-05 | 1316 | 19 | 7 | MM1052 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR | 3.58e-05 | 548 | 19 | 5 | MM1013 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN | 7.19e-05 | 113 | 19 | 3 | M9524 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 9.39e-05 | 20 | 19 | 2 | MM3682 | |
| Coexpression | HOWLIN_CITED1_TARGETS_2_UP | 1.04e-04 | 21 | 19 | 2 | MM712 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN | 1.48e-04 | 384 | 19 | 4 | M12527 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN | 2.62e-04 | 175 | 19 | 3 | M6750 | |
| Coexpression | SCHRAETS_MLL_TARGETS_DN | 3.27e-04 | 37 | 19 | 2 | MM1258 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_19_PRECICTIVE_ICB_RESPONSE | 3.71e-04 | 197 | 19 | 3 | MM17080 | |
| Coexpression | DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS | 4.22e-04 | 206 | 19 | 3 | M40237 | |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN | 4.92e-04 | 217 | 19 | 3 | M34023 | |
| Coexpression | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP | 5.50e-04 | 48 | 19 | 2 | MM649 | |
| Coexpression | KUNINGER_IGF1_VS_PDGFB_TARGETS_DN | 5.74e-04 | 49 | 19 | 2 | MM1174 | |
| Coexpression | HUPER_BREAST_BASAL_VS_LUMINAL_UP | 6.71e-04 | 53 | 19 | 2 | M13422 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 7.49e-04 | 56 | 19 | 2 | MM3852 | |
| Coexpression | CHANG_IMMORTALIZED_BY_HPV31_DN | 8.59e-04 | 60 | 19 | 2 | M12051 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 1.28e-03 | 302 | 19 | 3 | MM16604 | |
| Coexpression | SIRNA_EIF4GI_UP | 2.14e-03 | 95 | 19 | 2 | M2847 | |
| Coexpression | DESCARTES_FETAL_HEART_EPICARDIAL_FAT_CELLS | 2.90e-03 | 111 | 19 | 2 | M40192 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_UP | 2.95e-03 | 112 | 19 | 2 | MM1327 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_C | 3.16e-03 | 116 | 19 | 2 | M16130 | |
| CoexpressionAtlas | esophagus | ESPL1 SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D SPRR2E SPRR2F LCE3E | 5.06e-13 | 247 | 20 | 9 | esophagus |
| CoexpressionAtlas | skin | SPRR4 LCE3D SPRR2B LCE2D SPRR2E LCE2C LCE2A LCE4A LCE3E LCE2B | 2.88e-12 | 456 | 20 | 10 | skin |
| CoexpressionAtlas | tonsil | 2.14e-10 | 182 | 20 | 7 | tonsil | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 2.77e-08 | 98 | 20 | 5 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.66e-08 | 382 | 20 | 7 | JC_iEC_2500_K4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_1000 | 1.66e-06 | 990 | 20 | 8 | PCBC_ctl_BronchioEpithel_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_500 | 4.47e-06 | 493 | 20 | 6 | PCBC_ctl_SmallAirwayEpithel_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_500 | 4.62e-06 | 496 | 20 | 6 | PCBC_ctl_BronchioEpithel_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#4 | 2.25e-05 | 59 | 20 | 3 | Arv_EB-LF_500_K4 | |
| CoexpressionAtlas | BM Top 100 - tongue superior part w_papillae | 5.40e-05 | 79 | 20 | 3 | BM Top 100 - tongue superior part w_papillae | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_3 | 6.03e-05 | 82 | 20 | 3 | Facebase_ST1_Univ_500_3 | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 6.49e-05 | 84 | 20 | 3 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | BM Top 100 - esophagus | 6.96e-05 | 86 | 20 | 3 | BM Top 100 - esophagus | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#1_top-relative-expression-ranked_100 | 1.00e-04 | 16 | 20 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_100_k1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_100 | 1.03e-04 | 98 | 20 | 3 | PCBC_ctl_SmallAirwayEpithel_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#2_top-relative-expression-ranked_100 | 1.43e-04 | 19 | 20 | 2 | gudmap_developingLowerUrinaryTract_adult_bladder_100_k2 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.01e-04 | 123 | 20 | 3 | Arv_EB-LF_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#1_top-relative-expression-ranked_100 | 2.11e-04 | 23 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | 2.12e-04 | 981 | 20 | 6 | PCBC_ctl_BronchSmoothMuscl_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_1000 | 2.19e-04 | 987 | 20 | 6 | PCBC_ctl_SmallAirwayEpithel_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_200 | 2.70e-04 | 26 | 20 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_100 | 2.70e-04 | 26 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_100 | 3.14e-04 | 28 | 20 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k3_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_200 | 3.97e-04 | 155 | 20 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_200 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.05e-04 | 156 | 20 | 3 | ratio_MESO_vs_SC_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_200 | 5.81e-04 | 38 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_B_200_k3 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 6.05e-04 | 427 | 20 | 4 | Facebase_ST1_Univ_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#4_top-relative-expression-ranked_500 | 7.79e-04 | 44 | 20 | 2 | gudmap_developingLowerUrinaryTract_adult_ureter_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#2_top-relative-expression-ranked_200 | 8.51e-04 | 46 | 20 | 2 | gudmap_developingLowerUrinaryTract_adult_bladder_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_200 | 8.88e-04 | 47 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k1 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 9.08e-04 | 206 | 20 | 3 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_500 | 1.00e-03 | 489 | 20 | 4 | PCBC_ctl_BronchSmoothMuscl_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_200 | 1.17e-03 | 54 | 20 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#1_top-relative-expression-ranked_500 | 1.40e-03 | 59 | 20 | 2 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k1 | |
| CoexpressionAtlas | BM Top 100 - cervix | 1.74e-03 | 66 | 20 | 2 | BM Top 100 - cervix | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#5_top-relative-expression-ranked_500 | 1.85e-03 | 68 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k5 | |
| CoexpressionAtlas | BM Top 100 - tonsil | 1.96e-03 | 70 | 20 | 2 | BM Top 100 - tonsil | |
| CoexpressionAtlas | BM Top 100 - vagina | 2.30e-03 | 76 | 20 | 2 | BM Top 100 - vagina | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_top-relative-expression-ranked_100 | 2.36e-03 | 77 | 20 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_100 | 2.42e-03 | 78 | 20 | 2 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_100 | 2.49e-03 | 79 | 20 | 2 | gudmap_developingLowerUrinaryTract_adult_bladder_100 | |
| CoexpressionAtlas | BM Top 100 - tongue main corpus | 2.55e-03 | 80 | 20 | 2 | BM Top 100 - tongue main corpus | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_100 | 2.55e-03 | 80 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_ureter_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.61e-03 | 81 | 20 | 2 | gudmap_developingLowerUrinaryTract_adult_ureter_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_100 | 2.68e-03 | 82 | 20 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_100 | |
| CoexpressionAtlas | BM Top 100 - vulva | 2.68e-03 | 82 | 20 | 2 | BM Top 100 - vulva | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_100 | 2.74e-03 | 83 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_100_B | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_100 | 2.81e-03 | 84 | 20 | 2 | Facebase_ST1_Univ_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 2.94e-03 | 86 | 20 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_100 | 2.94e-03 | 86 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_100_J | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.06e-03 | 315 | 20 | 3 | ratio_MESO_vs_SC_2500_K5 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.34e-03 | 325 | 20 | 3 | Arv_EB-LF_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#5_top-relative-expression-ranked_500 | 3.57e-03 | 95 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k5 | |
| CoexpressionAtlas | ratio_StemCell-fibro_vs_StemCell-derived-from_CD34-iPSC_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.70e-03 | 337 | 20 | 3 | ratio_SC-fibro_vs_SC-cbCD34_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#3_top-relative-expression-ranked_500 | 3.87e-03 | 99 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K2 | 4.75e-03 | 110 | 20 | 2 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_500 | 5.56e-03 | 390 | 20 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500 | 5.63e-03 | 120 | 20 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.81e-03 | 122 | 20 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k3 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C LCE3E LCE2B | 1.93e-21 | 190 | 21 | 11 | e2b26a03c6ab24d9b0f4150c47597be37767d86e |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C LCE3E LCE2B | 1.93e-21 | 190 | 21 | 11 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D LCE2D SPRR2E LCE2C LCE3E LCE2B | 1.93e-21 | 190 | 21 | 11 | 01fb45add4661bc86cd0a34fac35177907152dbb |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | SPRR4 LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D SPRR2E SPRR2F LCE3E | 1.74e-19 | 172 | 21 | 10 | eb18aa179db1818f408c38e442ecfed8582d7dbc |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D SPRR2E SPRR2F LCE3E | 3.48e-18 | 132 | 21 | 9 | 780a391924f776dc6fbe44ddcf4ae0583a1e2157 |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | LCE3D SPRR1A SPRR1B SPRR2A SPRR2B SPRR2D SPRR2E SPRR2F LCE3E | 4.29e-18 | 135 | 21 | 9 | 366a417f9ef7c0d86e9f262d97bf788f478315ee |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-14 | 179 | 21 | 8 | 2b5f8e109a67c7fc3ec2b83e8f1854160c99283a | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.09e-14 | 195 | 21 | 8 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.36e-14 | 198 | 21 | 8 | b7495369baba203490c067a58fc8456a778a12e4 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-3|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.21e-13 | 125 | 21 | 7 | 5f90de494b53ecce6455034f3ed5dccdbb2c29ca | |
| ToppCell | PSB-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.82e-12 | 183 | 21 | 7 | 2cf798a2371c61322484ea16fdfae0acfa94f102 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.12e-12 | 187 | 21 | 7 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.55e-12 | 192 | 21 | 7 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.75e-12 | 194 | 21 | 7 | 53a34843d529ef395deb27086f71f7049a087bab | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.95e-12 | 196 | 21 | 7 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | moderate-Epithelial-Squamous|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.06e-12 | 197 | 21 | 7 | ab3c90a5b643b45d0b83939c6304b11f567c5d78 | |
| ToppCell | moderate-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.06e-12 | 197 | 21 | 7 | 2e13881f917d4f62a5b3e968e41c57e43300d988 | |
| ToppCell | critical-Epithelial-Squamous|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.06e-12 | 197 | 21 | 7 | eccc80d6ab79c46b10108de1cff3abeacfc105cd | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.06e-12 | 197 | 21 | 7 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | critical-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.06e-12 | 197 | 21 | 7 | cfbdaada7169afb68455724ae87032ff311b2d89 | |
| ToppCell | NS-control-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.06e-12 | 197 | 21 | 7 | ab965a0ba87efd3329d24a1ec123985f46fc17c0 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Metaplastic_Carcinoma-2|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.28e-12 | 92 | 21 | 6 | cad8b1b74a412988b2ae4f6126b2186100a2cdc2 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.33e-10 | 169 | 21 | 6 | 4a5d023ffcf83312d29b1d215eb6b744ef1a0777 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.43e-10 | 171 | 21 | 6 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | NS|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.95e-10 | 180 | 21 | 6 | 8472dcce7bc0b7ce428ec17ddf0018f3258f78d2 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.06e-10 | 194 | 21 | 6 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.25e-10 | 196 | 21 | 6 | 97e16d9833e4083d719ca7058d5fc9b11edb37e3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-10 | 197 | 21 | 6 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-10 | 197 | 21 | 6 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-10 | 197 | 21 | 6 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.35e-10 | 197 | 21 | 6 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-10 | 198 | 21 | 6 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | control-Epithelial-Squamous|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.46e-10 | 198 | 21 | 6 | 6ba669ac1ed275ae309054941b1457e315766faa | |
| ToppCell | control-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.56e-10 | 199 | 21 | 6 | e13dca7a055cdca53dd6c26c04b2a46d58b419b6 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.76e-09 | 123 | 21 | 5 | 51e49a64fbbf77e2ee21f45fd515d43282b11516 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.76e-09 | 123 | 21 | 5 | 11802979943a9205f10facda322fc220d4bf7133 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.29e-09 | 153 | 21 | 5 | b25629953ff79aff645845376132b12023067b01 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.29e-09 | 153 | 21 | 5 | e9d6b4e895ddb8d6e6c8b043da591ec11365e124 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.14e-08 | 163 | 21 | 5 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-08 | 166 | 21 | 5 | 006ced12f69ef13ddcba5a3891ddc7c18c384863 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.25e-08 | 166 | 21 | 5 | 6bb3410e65c971acc458c472015afcec6de6e310 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-08 | 166 | 21 | 5 | ac28c8cac1e94be0c47fb862c5809c92cdaa11f3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.25e-08 | 166 | 21 | 5 | 823ec03714884cb860a1260410feac8c536b6d06 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-08 | 170 | 21 | 5 | 13a225e32132e9717debb0d64d7c28ada974c3e6 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.72e-08 | 177 | 21 | 5 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-08 | 185 | 21 | 5 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.39e-08 | 189 | 21 | 5 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | BL-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.52e-08 | 191 | 21 | 5 | 3f9b8c4fb72ae6f3167b187e6715c4dcb3159f98 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-08 | 191 | 21 | 5 | fbd8d337b4444fba8527a614e4a8bfb516ce0f66 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.79e-08 | 195 | 21 | 5 | 82d87fdb39ec15be9057e2d2ba5c1afb5f97aafe | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.79e-08 | 195 | 21 | 5 | dd8117dbd22892288f74a7314ab0b5080106936c | |
| ToppCell | NS-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.87e-08 | 196 | 21 | 5 | 453c809494ceffa2a28af283c4b5a4924fcf160f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.94e-08 | 197 | 21 | 5 | ac9c0c25cfeaabd53d332982c73fc6c47b0c6478 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-08 | 197 | 21 | 5 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-08 | 197 | 21 | 5 | 7870c0651caefb0ed13d9f9dab43b5f24d6a9efc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.94e-08 | 197 | 21 | 5 | b57d2e3413ef6dd1da56c45087926f2f3eab876c | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.09e-08 | 199 | 21 | 5 | 8be7cb9d8b4f9707efb69c681c40e683fcd810e5 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Recurrent_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 9.54e-08 | 92 | 21 | 4 | b728c0faf742c9235b891e3acf34d18a0e335c22 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Recurrent_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 9.54e-08 | 92 | 21 | 4 | 207cde9de6f37b33e47bc6f9c32c9877ab7cbe63 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-2|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.01e-07 | 139 | 21 | 4 | 6f6c64eaa1ce84e0aa9a0caa9c4d9bf7afe626df | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.02e-06 | 166 | 21 | 4 | 8ac0a769be886d16642e7e6334471ebadd1a426b | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.04e-06 | 167 | 21 | 4 | 806d1c00c137da0c5f042adf866873eb6dd4bb27 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-6|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.12e-06 | 170 | 21 | 4 | 3dba3f810fbd1eadf446b52e4c9c971d362a80e1 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-06 | 171 | 21 | 4 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-06 | 171 | 21 | 4 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.29e-06 | 176 | 21 | 4 | 8513c2a05a34453a16bbcf1c11cb34c580133e47 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 180 | 21 | 4 | 18bf8561ad3aa9787d2a8ef942a96f641734c608 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 1.53e-06 | 184 | 21 | 4 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Late_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.67e-06 | 188 | 21 | 4 | 38a53f99f1876359983936403aefca93281d10fd | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 1.71e-06 | 189 | 21 | 4 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.71e-06 | 189 | 21 | 4 | 533c302df467d13ab639232daf4f8cafb808260b | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 190 | 21 | 4 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 1.74e-06 | 190 | 21 | 4 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-06 | 191 | 21 | 4 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-06 | 192 | 21 | 4 | 24fb2f1e6f49ab5b71876e105c0ee7f59e7d64e8 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 193 | 21 | 4 | f074ebf9c5c53d8589d66b0109505f30baa1af81 | |
| ToppCell | CTRL-Epithelial-Epithelial_cell|CTRL / Disease state, Lineage and Cell class | 1.89e-06 | 194 | 21 | 4 | 2bc4deaf2a01a39809fc323962fce4286835209c | |
| ToppCell | CTRL-Epithelial|CTRL / Disease state, Lineage and Cell class | 1.89e-06 | 194 | 21 | 4 | 49dcb31427f370692308f939e23992925708abb7 | |
| ToppCell | distal-1-Epithelial-Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.01e-06 | 197 | 21 | 4 | 25a2ccc98b973611de0d920b1b455d0b40f0d37f | |
| ToppCell | distal-Epithelial-Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.01e-06 | 197 | 21 | 4 | 75b4292ce2ad7f9c8b6a4781e1cb71f5b18b74e3 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.05e-06 | 198 | 21 | 4 | a3d4b6e4259ded2193d94d2ff6d48cf67214fc35 | |
| ToppCell | 367C|World / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-06 | 198 | 21 | 4 | ab3a178f392204e2d90eb5a3b5de7849986b1eaf | |
| ToppCell | (08)_Brush+PNEC|World / shred by cell type by condition | 2.10e-06 | 199 | 21 | 4 | f2e33cb569c25fc2732722cac295647e9bd8738f | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-06 | 200 | 21 | 4 | 5f0f67958c9635db53e61f8370a92da6ea3e80fe | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.14e-06 | 200 | 21 | 4 | 0fa3340d945f00ef55c7603476d51bd8346e82c2 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.91e-06 | 71 | 21 | 3 | ab476ee0b91d91d44d4324da18e2e7938bba3d2c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-7|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.62e-05 | 124 | 21 | 3 | c6e0c45e9ac128540baddfeb4599a0d5ec3f14cb | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.09e-05 | 131 | 21 | 3 | 2ccf679b5035b7b9cdb9a9a660cad90288592187 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.19e-05 | 156 | 21 | 3 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.81e-05 | 162 | 21 | 3 | 112fa4de685727f6c8bf6fc4afb82de0524070ad | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.03e-05 | 164 | 21 | 3 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 6.25e-05 | 166 | 21 | 3 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 6.36e-05 | 167 | 21 | 3 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 172 | 21 | 3 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.18e-05 | 174 | 21 | 3 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.31e-05 | 175 | 21 | 3 | 8ccf60fc469059d7aaf4e6ce54159db2962e0060 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.31e-05 | 175 | 21 | 3 | 8252ddc2ca95071381f0354aefb70c4714828491 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.56e-05 | 177 | 21 | 3 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.07e-05 | 181 | 21 | 3 | 58651853f9c715075889856793df66ebe00c04f1 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.07e-05 | 181 | 21 | 3 | faff2a34e391d053a17c926540e6cb46d94dd629 | |
| Computational | Neighborhood of SPRR1B | 1.95e-07 | 24 | 6 | 3 | GNF2_SPRR1B | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.88e-06 | 50 | 6 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE | |
| Computational | Genes in the cancer module 153. | 1.45e-04 | 34 | 6 | 2 | MODULE_153 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.14e-04 | 50 | 6 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Drug | 4-tert-octylphenol | 2.22e-07 | 159 | 20 | 5 | ctd:C105260 | |
| Drug | NSC19448 | 3.20e-06 | 273 | 20 | 5 | CID000003054 | |
| Drug | Diethylstilbestrol | 7.72e-06 | 1305 | 20 | 8 | ctd:D004054 | |
| Disease | psoriasis, COVID-19 | 3.51e-07 | 2 | 18 | 2 | EFO_0000676, MONDO_0100096 | |
| Disease | Psoriasis | 5.46e-06 | 57 | 18 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 5.46e-06 | 57 | 18 | 3 | C0030246 | |
| Disease | level of C-X-C motif chemokine 2 in blood serum | 2.31e-05 | 12 | 18 | 2 | OBA_2041207 | |
| Disease | level of C-X-C motif chemokine 3 in blood serum | 3.67e-05 | 15 | 18 | 2 | OBA_2041208 | |
| Disease | psoriasis | 5.77e-04 | 273 | 18 | 3 | EFO_0000676 | |
| Disease | allergic disease, age at onset | 8.52e-04 | 71 | 18 | 2 | EFO_0004847, MONDO_0005271 | |
| Disease | vitamin D measurement | 1.05e-03 | 336 | 18 | 3 | EFO_0004631 | |
| Disease | allergic disease | 1.06e-02 | 258 | 18 | 2 | MONDO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGKQQAQVPCPPQLP | 1081 | Q14674 | |
| KPPICQQIFCPNPPA | 466 | Q2VPA4 | |
| NQQQCQPPPKCPPKC | 6 | Q5TA79 | |
| NQQQCQPPPKCPPKC | 6 | O14633 | |
| NQQQCQPPPKCPPKC | 6 | Q5TA81 | |
| NQQQCQPPPKCPPKC | 6 | Q5TA82 | |
| NQQQCQPLPKCPSPK | 6 | Q5TA77 | |
| NQQQCQPPPSCPSPK | 6 | Q5T5A8 | |
| NQQQCQPPPKCPSPK | 6 | Q9BYE3 | |
| NQKQCQPPPKCPSPK | 6 | Q5T5B0 | |
| NQQQCQPPPKCPIPK | 6 | Q5TA78 | |
| QQVKQPCQPPPVKCQ | 21 | Q96PI1 | |
| QKQCAPPQQCCPPPQ | 6 | A0A1B0GTR4 | |
| QRCPPPQQCCPPPQQ | 21 | A0A1B0GTR4 | |
| QQCCPPPQQCCPPPQ | 41 | A0A1B0GTR4 | |
| QCCPPPQQCCPPPQQ | 56 | A0A1B0GTR4 | |
| YCPPPQQTKQPCQPP | 71 | A0A1B0GTR4 | |
| QQTKQPCQPPPKCQE | 76 | A0A1B0GTR4 | |
| TPPPQPQQQQVKQPC | 11 | P35321 | |
| VKQPCQPPPQEPCIP | 21 | P35321 | |
| VKQPCQPPPQEPCIP | 21 | P22528 | |
| CPQPCPPQQCQQKYP | 41 | P35326 | |
| CPQPCPPQQCQQKYP | 41 | P35325 | |
| CPQPCPPQQCQQKYP | 41 | P22532 | |
| PPQQCQQKCPPVTPS | 46 | P22531 | |
| QQCKQPCQPPPVCPA | 6 | Q96RM1 | |
| PPQQCQQKCPPVTPS | 46 | Q96RM1 | |
| QQCKQPCVPPPCLPK | 6 | Q5T870 |